Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
ALS Awareness Month is drawing to a close, but our efforts to create a future without ALS continue year-round. Driven by the ALS community, we look to create connection and impact, sharing the progress towards our mission along the way....
June 13, 2022 – Today, Amylyx Pharmaceuticals, Inc announced that Health Canada has approved ALBRIOZA (AMX0035) under a Notice of Compliance with Conditions (NOC/c). This means the drug will soon...
Read the update